Progyny, Inc. (NASDAQ:PGNY) Receives $25.42 Consensus Target Price from Analysts

Progyny, Inc. (NASDAQ:PGNY - Get Free Report) has earned a consensus rating of "Hold" from the thirteen research firms that are covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $25.42.

Several research firms recently issued reports on PGNY. Cantor Fitzgerald reissued an "overweight" rating and issued a $25.00 target price on shares of Progyny in a report on Tuesday, October 1st. Leerink Partnrs downgraded shares of Progyny from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, August 7th. Leerink Partners lowered their target price on shares of Progyny from $25.00 to $21.00 and set a "market perform" rating on the stock in a research note on Thursday, September 19th. Jefferies Financial Group cut their price target on Progyny from $31.00 to $24.00 and set a "buy" rating for the company in a research note on Thursday, September 19th. Finally, Canaccord Genuity Group downgraded Progyny from a "buy" rating to a "hold" rating and lowered their price objective for the company from $37.00 to $24.00 in a research report on Wednesday, August 7th.

Hedge Funds Weigh In On Progyny

Institutional investors have recently modified their holdings of the stock. Disciplined Growth Investors Inc. MN boosted its stake in shares of Progyny by 56.5% during the third quarter. Disciplined Growth Investors Inc. MN now owns 826,726 shares of the company's stock valued at $13,856,000 after purchasing an additional 298,314 shares in the last quarter. Barclays PLC boosted its position in Progyny by 530.4% during the 3rd quarter. Barclays PLC now owns 706,157 shares of the company's stock valued at $11,835,000 after acquiring an additional 594,140 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in shares of Progyny in the 3rd quarter valued at $469,000. Wellington Management Group LLP raised its position in shares of Progyny by 4.0% in the 3rd quarter. Wellington Management Group LLP now owns 430,300 shares of the company's stock worth $7,212,000 after acquiring an additional 16,638 shares in the last quarter. Finally, Wolverine Trading LLC lifted its stake in shares of Progyny by 131.5% during the 3rd quarter. Wolverine Trading LLC now owns 19,677 shares of the company's stock worth $331,000 after purchasing an additional 11,177 shares during the last quarter. 94.93% of the stock is owned by hedge funds and other institutional investors.

Progyny Price Performance

Shares of PGNY traded down $0.21 on Friday, reaching $13.77. The company's stock had a trading volume of 2,387,756 shares, compared to its average volume of 1,398,215. The stock's 50 day simple moving average is $17.49 and its two-hundred day simple moving average is $23.49. The stock has a market capitalization of $1.17 billion, a P/E ratio of 24.10, a PEG ratio of 1.31 and a beta of 1.44. Progyny has a 12-month low of $13.39 and a 12-month high of $42.08.

Progyny (NASDAQ:PGNY - Get Free Report) last issued its quarterly earnings data on Tuesday, November 12th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.26). The business had revenue of $286.63 million for the quarter, compared to the consensus estimate of $296.85 million. Progyny had a net margin of 5.03% and a return on equity of 11.36%. The company's revenue was up 2.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.16 EPS. Analysts expect that Progyny will post 0.64 earnings per share for the current year.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.